Every Cure Co-founder Dr. David Fajgenbaum addressed the audience at the Clinton Global Initiative 2023 Meeting by giving Every Cure’s Commitment to Action to unlock
News & Media
Every Cure Announces Foundational Funding Partners and Major Milestones at Clinton Global Initiative 2023 Meeting
Partnerships with the Chan Zuckerberg Initiative, Flagship Pioneering, Lyda Hill Philanthropies, and Elevate Prize Foundation Will Accelerate the Discovery of Cures Hidden on Pharmacy Shelves
Every Cure Announces Leaders Across Healthcare Joining its Board of Directors
Board of Directors will lead the nonprofit organization on its mission of unlocking hidden cures. Share this
From Bedside to Bench and Back
Research driven by patients with rare diseases is producing faster discoveries and treatments—and challenging long-held assumptions about knowledge production. Share this
From Coma to Cure: The Inspiring Tale of Battling Castleman Disease with Drug Repurposing
Imagine feeling like you’ve contracted the flu, only to fall into a coma three days later. This was Gary’s reality, an experience he describes as
Every Cure Featured In Nature Reviews – Drug Discovery
Have you read the story of David Fajgenbaum, a physician who was diagnosed with the rare disease called Castleman disease? Share this
Angiosarcoma Patient Celebrates 7-Year Remission with Pioneering Use of PD-1 Inhibitor: Every Cure Unleashes AI to Ensure No Treatment is Left Overlooked
An Angiosarcoma patient facing a grave prognosis found a lifeline in a repurposed PD-1 inhibitor, a treatment hidden in the medical literature for three years.
Every Cure Co-Founder David Fajgenbaum Addresses The Rare Disease Congressional Caucus!
In a recent address to the Rare Disease Congressional Caucus, David Fajgenbaum, the co-founder of Every Cure, unveiled the organization’s mission to repurposing FDA-approved drugs
Life saved: AI discovers existing drug works for rare disease
A patient’s life was saved after researchers at the University of Pennsylvania, Castleman Disease Collaborative Network, Medidata, and Every Cure, used artificial intelligence to use
Of course, AI was on everyone’s minds at the conference. However, it was the proof points and examples shared by leaders from multiple organizations that
Emerging AI Trends in CRO Development and Clinical Trials
The adoption of AI is accelerating across the entire CRO space as we start to explore the benefits of the tech. Whether being utilised for
Aspen, Colorado – David Fajgenbaum, co-founder of Every Cure and physician-scientist at the University of Pennsylvania, unveiled his ‘Big Idea’ to repurpose existing drugs for
Every Cure Co-Founders Honored at the Clinton Foundation Gala
New York, New York – Every Cure, a nonprofit organization dedicated to unlocking the full potential of existing drugs for the treatment of various diseases,
Every Cure Invited to the White House!
Every Cure has raised significant awareness over the last year and engaged with leaders across healthcare and government. In fact, Every Cure Co-Founders Grant Mitchell
David Fajgenbaum announced as Keynote Speaker of LSU Health Shreveport 50th Commencement
We are very excited to have Dr. David Fajgenbaum as our student-selected keynote speaker on this momentous occasion of our 50th commencement ceremony. His impressive and
Every Cure Co-founder David Fajgenbaum Presents at the Elevate Prize’s Make Good Famous Summit
Miami, Florida – David Fajgenbaum, co-founder of Every Cure, delivered a presentation at the Elevate Prize’s Make Good Famous Summit, sharing his journey with illness
Rare Disease: Could Existing Drugs Turn the Tide?
In September 2022, Fajgenbaum joined forces with longtime friend and fellow doctor Grant Mitchell, MD, and a group of experts at the University of North
Worldwide Clinical Trials Partners with Every Cure to Accelerate Discovery of Treatments for Rare Disease Patients
Worldwide Clinical Trials (Worldwide), the industry’s leading global, full-service contract research organization (CRO), has partnered with Every Cure, a nonprofit organization that unlocks new, often
David Fajgenbaum is an immunologist and co-founder of Every Cure, a nonprofit organization whose mission is to unlock the full potential of approved medicines to
Every Cure Announces Breakthrough at STAT Summit
San Francisco, California – David Fajgenbaum, co-founder of Every Cure and physician-scientist at the University of Pennsylvania, announces First Life Saved with AI-Discovered Repurposed Medicine

From Treating His Own Rare Disease to Treating Many – David Fajgenbaum 2023 STAT Breakthrough Summit
Fajgenbaum was having his last rites read to him, and his family braced for his death from Castleman disease, a rare inflammatory illness that impacts
A 50-year-old patient battling life-threatening Castleman disease was provided adalimumab as a treatment of last resort following its identification by AI-guided discovery. Every Cure and
About a decade ago, David Fajgenbaum thought his life was over. He was a young, bright physician hoping to work in oncology in remembrance of
David Fajgenbaum has become a “man on fire,” determined to repurpose as many generic drugs as possible for diseases without approved treatments. Fajgenbaum, whose efforts
Two companies team up to combat rare diseases through drug repurposing, which was heavily informed by one doctor’s experience through unconventionally treating his Castleman disease
This Doctor Almost Died 5 Times From a Rare Disease — Here’s How He’s Fighting Back
David Fajgenbaum, MD, was a college football player at Georgetown University in 2004 when his mother passed away from cancer. The loss inspired the athlete
How Rare Disease Patients Are Fighting Their Conditions Head-On
As many as 7,000 rare diseases affect 300 million people globally. The vast majority are not well understood, and less than 5 percent have approved
Drug Repurposing Provides Big Impact for Patients
Dr. David Fajgenbaum is not afraid to think outside the box and that is what saved his life. While in medical school, the former college
Chasing Every Cure
It was the night before April Fools’ Day, 2021, when Dr. David Fajgenbaum received the text: President Clinton read your book and would like to
5 Things to Know About Dr. David Fajgenbaum
The Philadelphia physician has the distinction of researching – and solving – his own rare disease. Learn more about this prolific advocate for rare disease
A Personal Case For Drug Repurposing
For biotechs, the JP Morgan Healthcare Conference is about dealmaking in many forms—securing financing, establishing development partnerships, courting mergers and acquisitions—by wooing would-be partners and
Medable and Every Cure announce partnership for remote clinical trials –
Medable has announced a collaboration with non-profit Every Cure for conducting global, remote clinical trials for drug repurposing candidates. Every Cure was officially launched, in
Medable Partners with Every Cure to Accelerate Discovery of Treatments for Rare Diseases
Medable Inc., the industry-leading technology platform for patient-centered clinical trials, today announced a partnership with non-profit Every Cure, which officially launched in September in partnership
A Journey of Hope and Progress: Chasing My Cure on President Biden’s Desk
President Biden found a copy of the book “Chasing My Cure” on his desk, a gift from none other than former President Clinton. Share this
How a Doctor Faced Down His Rare Disease
This week, an exciting interview from our archive airs on Oct. 8, 2022. A healthy young medical student, David Fajgenbaum, had been a student athlete
6ABC – New nonprofit aims to identify unrelated generic drugs to help cure rare diseases
A new nonprofit backed by the Clinton Global Initiative aims to identify generic drugs that could help people with rare diseases. Every Cure is based
Every Cure Launches at the Clinton Global Initiative
Approximately 75% of human diseases don’t have a single FDA-approved treatment. That fact nearly cost Dr. David Fajgenbaum his life, and at #CGI2022, he announced
Clinton Global Initiative gathers for first time since 2016
Former President Bill Clinton is calling on governments, businesses, philanthropies and other prominent institutions to draw together and help a world that is “on fire”
ABC7 – New nonprofit aims to identify unrelated generic drugs to help cure rare diseases –
A new nonprofit backed by the Clinton Global Initiative aims to identify generic drugs that could help people with rare diseases. Every Cure is based
New uses for old drugs? Every Cure offers hope for people with rare diseases
Every drug on the market has multiple effects on the body, not just the one or two that won it approval. A new nonprofit aims to